OSR Health, Inc. (OSRH)
Develops immunotherapy cancer drugs and biologics for bone and joint repair.
$0.46+0.06%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-28.9%
The outlook
OSRH is trading near its 52-week lows with mixed momentum against its moving averages. Analyst coverage shows a wide spread, with the average price target significantly above current levels, though such targets should be weighed carefully given the stock's low valuation metrics and recent trading range.
What’s behind the score
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +2090% vs current price
Market cap
$16.0M
52-wk high
$1.24
52-wk low
$0.30
50-day avg
$0.41
200-day avg
$0.54
Trailing P/E
15.2